Works matching IS 02780232 AND DT 2022 AND VI 40 AND IP 3

Results: 20
    1

    Targeting MYC and BCL2 by a natural compound for "double‐hit" lymphoma.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 3, p. 356, doi. 10.1002/hon.3010
    By:
    • Liu, Xiaoqian;
    • Xu, Senlin;
    • Zhang, Jiawei;
    • Fan, Mingjie;
    • Xie, Jun;
    • Zhang, Bingfeng;
    • Li, Hongzhi;
    • Yu, Guohua;
    • Liu, Yinghui;
    • Zhang, Yuanfeng;
    • Song, Joo;
    • Horne, David;
    • Chan, Wing C.;
    • Chu, Xiaoxia;
    • Huang, Wendong
    Publication type:
    Article
    2
    3
    4
    5
    6

    Prognostic significance of IKZF1 deletions and IKZF1<sup>plus</sup> profile in children with B‐cell precursor acute lymphoblastic leukemia treated according to the ALL‐IC BFM 2009 protocol.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 3, p. 430, doi. 10.1002/hon.2973
    By:
    • Braun, Marcin;
    • Pastorczak, Agata;
    • Sędek, Łukasz;
    • Taha, Joanna;
    • Madzio, Joanna;
    • Jatczak‐Pawlik, Izabela;
    • Wypyszczak, Kamila;
    • Matysiak, Michał;
    • Derwich, Katarzyna;
    • Lejman, Monika;
    • Kazanowska, Bernarda;
    • Szczepański, Tomasz;
    • Kowalczyk, Jerzy R.;
    • Mlynarski, Wojciech
    Publication type:
    Article
    7
    8
    9
    10
    11

    The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 3, p. 442, doi. 10.1002/hon.3000
    By:
    • Shimazu, Yutaka;
    • Murata, Makoto;
    • Kondo, Takeshi;
    • Minami, Yosuke;
    • Tachibana, Takayoshi;
    • Doki, Noriko;
    • Uchida, Naoyuki;
    • Ozawa, Yukiyasu;
    • Yano, Shingo;
    • Fukuda, Takahiro;
    • Kato, Jun;
    • Ara, Takahide;
    • Eto, Testuya;
    • Ishikawa, Jun;
    • Nakamae, Hirohisa;
    • Tanaka, Junji;
    • Ichinohe, Tatsuo;
    • Atsuta, Yoshiko;
    • Nagamura‐Inoue, Tokiko
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18

    Prognostic factors of children and adolescents with T‐cell acute lymphoblastic leukemia after allogeneic transplantation.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 3, p. 457, doi. 10.1002/hon.2980
    By:
    • Ishida, Hisashi;
    • Kato, Motohiro;
    • Kawahara, Yuta;
    • Ishimaru, Sae;
    • Najima, Yuho;
    • Kako, Shinichi;
    • Sato, Maho;
    • Hiwatari, Mitsuteru;
    • Noguchi, Maiko;
    • Kato, Keisuke;
    • Koh, Katsuyoshi;
    • Okada, Keiko;
    • Iwasaki, Fuminori;
    • Kobayashi, Ryoji;
    • Igarashi, Shunji;
    • Saito, Shoji;
    • Takahashi, Yoshiyuki;
    • Sato, Atsushi;
    • Tanaka, Junji;
    • Hashii, Yoshiko
    Publication type:
    Article
    19

    The safety and clinical effectiveness of rapid infusion with CT‐P10 in patients with non‐Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non‐interventional post‐authorization safety study in Europe.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 3, p. 370, doi. 10.1002/hon.2978
    By:
    • Bishton, Mark;
    • Marshall, Scott;
    • Harchowal, Jatinder;
    • Salles, Gilles;
    • Golfier, Camille;
    • Tucci, Alessandra;
    • Fernández, Alicia Rodriguez;
    • Sanchez Blanco, Jose Javier;
    • Bocchia, Monica;
    • Kim, SooKyoung;
    • Lee, Young Nam;
    • Zinzani, Pier Luigi
    Publication type:
    Article
    20

    Issue Information.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 3, p. 311, doi. 10.1002/hon.2891
    Publication type:
    Article